Possible modification of Alzheimer’s disease by statins in midlife: interactions with genetic and non-genetic risk factors

The benefits of statins, commonly prescribed for hypercholesterolemia, in treating Alzheimer’s disease (AD) have not yet been fully established. A recent randomized clinical trial did not show any therapeutic effects of two statins on cognitive function in AD. Interestingly, however, the results of...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinohara, Mitsuru, Sato, Naoyuki, Shimamura, Munehisa, Kurinami, Hitomi, Hamasaki, Toshimitsu, Chatterjee, Amarnath, Rakugi, Hiromi, Morishita, Ryuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005936/
https://www.ncbi.nlm.nih.gov/pubmed/24795626
http://dx.doi.org/10.3389/fnagi.2014.00071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005936/
https://www.ncbi.nlm.nih.gov/pubmed/24795626
http://dx.doi.org/10.3389/fnagi.2014.00071

Ejemplares similares